H40.1 H17
Conditions
Interventions
Group 1: All naive patients after implantation of a XEN 45 micro stent in at least one eye will be examined once postoperatively on an outpatient basis with regard to safety and the glaucoma stage. Th
Sponsors
Dietrich Bonhoeffer Klinikum, Klinik für Augenheilkunde
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: - Patients 2 to 5 years after implantation of a XEN 45 stent (2013-2018) - Willingness of patients to participate in the study and written consent.
Exclusion criteria
Exclusion criteria: - Patients with a distant place of residence or with a limited general condition due to illness, who cannot be expected to travel to Neubrandenburg. - Patients who have moved unknown. - Deceased patients (existing data are documented). - Patients who are not interested in participating in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Determination of the effect of the XEN 45 microstent implantation on intraocular pressure, the number of necessary antiglaucomatous therapies, the progression of glaucoma in terms of visual field deterioration and progression of glaucomatous papillary changes and the loss of endothelial cells. | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety of the procedure based on the intra- and post-operative complications that have occurred. Development of the stent-associated conjunctival filtering bleb, Long-term success rate of the XEN 45 stent Clinical identification of stent failure. | — |
Countries
Germany
Contacts
Public ContactUlrike Holland
Diakonie Klinikum Dietrich Bonhoeffer GmbH
Outcome results
None listed